Watermark

BGB-A317-A445-101

Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-A445-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2022-501177-39-00

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20220453

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents